180 related articles for article (PubMed ID: 34876442)
1. Alkaptonuria: clinical manifestations and an updated approach to treatment of a rare disease.
Roopnarinesingh RC; Donlon NE; Reynolds JV
BMJ Case Rep; 2021 Dec; 14(12):. PubMed ID: 34876442
[TBL] [Abstract][Full Text] [Related]
2. Homogentisic acid induces morphological and mechanical aberration of ochronotic cartilage in alkaptonuria.
Bernardini G; Leone G; Millucci L; Consumi M; Braconi D; Spiga O; Galderisi S; Marzocchi B; Viti C; Giorgetti G; Lupetti P; Magnani A; Santucci A
J Cell Physiol; 2019 May; 234(5):6696-6708. PubMed ID: 30341892
[TBL] [Abstract][Full Text] [Related]
3. Ochronotic arthritis and ochronotic Achilles tendon rupture in alkaptonuria: A 6 years follow-up case report in China.
Jiang L; Cao L; Fang J; Yu X; Dai X; Miao X
Medicine (Baltimore); 2019 Aug; 98(34):e16837. PubMed ID: 31441856
[TBL] [Abstract][Full Text] [Related]
4. Alkaptonuria: a very rare metabolic disorder.
Aquaron R
Indian J Biochem Biophys; 2013 Oct; 50(5):339-44. PubMed ID: 24772955
[TBL] [Abstract][Full Text] [Related]
5. Development of an in vitro model to investigate joint ochronosis in alkaptonuria.
Tinti L; Taylor AM; Santucci A; Wlodarski B; Wilson PJ; Jarvis JC; Fraser WD; Davidson JS; Ranganath LR; Gallagher JA
Rheumatology (Oxford); 2011 Feb; 50(2):271-7. PubMed ID: 20952450
[TBL] [Abstract][Full Text] [Related]
6. Alkaptonuria.
Bernardini G; Braconi D; Zatkova A; Sireau N; Kujawa MJ; Introne WJ; Spiga O; Geminiani M; Gallagher JA; Ranganath LR; Santucci A
Nat Rev Dis Primers; 2024 Mar; 10(1):16. PubMed ID: 38453957
[TBL] [Abstract][Full Text] [Related]
7. Ochronotic osteoarthropathy in a mouse model of alkaptonuria, and its inhibition by nitisinone.
Preston AJ; Keenan CM; Sutherland H; Wilson PJ; Wlodarski B; Taylor AM; Williams DP; Ranganath LR; Gallagher JA; Jarvis JC
Ann Rheum Dis; 2014 Jan; 73(1):284-9. PubMed ID: 23511227
[TBL] [Abstract][Full Text] [Related]
8. Calcaneal Avulsion of an Ochronotic Achilles Tendon: A Case Report.
Tanoğlu O; Arıcan G; Özmeriç A; Alemdaroğlu KB; Çaydere M
J Foot Ankle Surg; 2018; 57(1):179-183. PubMed ID: 29113706
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of antioxidant drugs for the treatment of ochronotic alkaptonuria in an in vitro human cell model.
Tinti L; Spreafico A; Braconi D; Millucci L; Bernardini G; Chellini F; Cavallo G; Selvi E; Galeazzi M; Marcolongo R; Gallagher JA; Santucci A
J Cell Physiol; 2010 Oct; 225(1):84-91. PubMed ID: 20648626
[TBL] [Abstract][Full Text] [Related]
10. Homogentisic acid induces autophagy alterations leading to chondroptosis in human chondrocytes: Implications in Alkaptonuria.
Galderisi S; Milella MS; Rossi M; Cicaloni V; Rossi R; Giustarini D; Spiga O; Tinti L; Salvini L; Tinti C; Braconi D; Millucci L; Lupetti P; Prischi F; Bernardini G; Santucci A
Arch Biochem Biophys; 2022 Mar; 717():109137. PubMed ID: 35090868
[TBL] [Abstract][Full Text] [Related]
11. A Mimic of Ankylosing Spondylitis, Ochronosis: Case Report and Review of the Literature.
Chu P; Cuellar MC; Bracken SJ; Tarrant TK
Curr Allergy Asthma Rep; 2021 Mar; 21(3):19. PubMed ID: 33666743
[TBL] [Abstract][Full Text] [Related]
12. The role of calcified cartilage and subchondral bone in the initiation and progression of ochronotic arthropathy in alkaptonuria.
Taylor AM; Boyde A; Wilson PJ; Jarvis JC; Davidson JS; Hunt JA; Ranganath LR; Gallagher JA
Arthritis Rheum; 2011 Dec; 63(12):3887-96. PubMed ID: 22127706
[TBL] [Abstract][Full Text] [Related]
13. [Ochronosis: A case report].
Erraoui K; Nassar K; Janani S
Rev Med Interne; 2022 Nov; 43(11):669-672. PubMed ID: 35659777
[TBL] [Abstract][Full Text] [Related]
14. Calculi and intracellular ochronosis in the submandibular tissues from a patient with alkaptonuria.
Taylor AM; Wilson PJ; Ingrams DR; Helliwell TR; Gallagher JA; Ranganath LR
J Clin Pathol; 2010 Feb; 63(2):186-8. PubMed ID: 20154043
[TBL] [Abstract][Full Text] [Related]
15. Alkaptonuric ochronosis with aortic valve and joint replacements and femoral fracture: a case report and literature review.
Fisher AA; Davis MW
Clin Med Res; 2004 Nov; 2(4):209-15. PubMed ID: 15931360
[TBL] [Abstract][Full Text] [Related]
16. Amyloidosis in alkaptonuria.
Millucci L; Braconi D; Bernardini G; Lupetti P; Rovensky J; Ranganath L; Santucci A
J Inherit Metab Dis; 2015 Sep; 38(5):797-805. PubMed ID: 25868666
[TBL] [Abstract][Full Text] [Related]
17. Oxidative stress and mechanisms of ochronosis in alkaptonuria.
Braconi D; Millucci L; Bernardini G; Santucci A
Free Radic Biol Med; 2015 Nov; 88(Pt A):70-80. PubMed ID: 25733348
[TBL] [Abstract][Full Text] [Related]
18. Ochronotic pigmentation is caused by homogentisic acid and is the key event in alkaptonuria leading to the destructive consequences of the disease-A review.
Ranganath LR; Norman BP; Gallagher JA
J Inherit Metab Dis; 2019 Sep; 42(5):776-792. PubMed ID: 31282009
[TBL] [Abstract][Full Text] [Related]
19. Ochronosis and lumbar disc herniation.
Gürkanlar D; Daneyemez M; Solmaz I; Temiz C
Acta Neurochir (Wien); 2006 Aug; 148(8):891-4; discussion 894. PubMed ID: 16736091
[TBL] [Abstract][Full Text] [Related]
20. Natural history of alkaptonuria revisited: analyses based on scoring systems.
Ranganath LR; Cox TF
J Inherit Metab Dis; 2011 Dec; 34(6):1141-51. PubMed ID: 21748407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
